JP2019519488A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019519488A5 JP2019519488A5 JP2018558225A JP2018558225A JP2019519488A5 JP 2019519488 A5 JP2019519488 A5 JP 2019519488A5 JP 2018558225 A JP2018558225 A JP 2018558225A JP 2018558225 A JP2018558225 A JP 2018558225A JP 2019519488 A5 JP2019519488 A5 JP 2019519488A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- polymer
- polymer matrix
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 86
- 229920000642 polymer Polymers 0.000 claims description 51
- 239000011159 matrix material Substances 0.000 claims description 34
- 239000000419 plant extract Substances 0.000 claims description 22
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 20
- 239000004480 active ingredient Substances 0.000 claims description 19
- 229930015704 phenylpropanoid Natural products 0.000 claims description 17
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 244000223014 Syzygium aromaticum Species 0.000 claims description 13
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 claims description 13
- 239000000341 volatile oil Substances 0.000 claims description 13
- 150000004676 glycans Chemical class 0.000 claims description 12
- 229920001282 polysaccharide Polymers 0.000 claims description 12
- 239000005017 polysaccharide Substances 0.000 claims description 12
- 108060003345 Adrenergic Receptor Proteins 0.000 claims description 10
- 102000017910 Adrenergic receptor Human genes 0.000 claims description 10
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 10
- 239000005770 Eugenol Substances 0.000 claims description 10
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 10
- 229960002217 eugenol Drugs 0.000 claims description 10
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 10
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 10
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 10
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 10
- 239000003961 penetration enhancing agent Substances 0.000 claims description 10
- 229920001577 copolymer Polymers 0.000 claims description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 9
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 claims description 8
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 claims description 8
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 7
- 229930016911 cinnamic acid Natural products 0.000 claims description 7
- 235000013985 cinnamic acid Nutrition 0.000 claims description 7
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 7
- 229920000084 Gum arabic Polymers 0.000 claims description 6
- 235000010489 acacia gum Nutrition 0.000 claims description 6
- 239000000205 acacia gum Substances 0.000 claims description 6
- -1 cavicol Chemical compound 0.000 claims description 6
- 229920000609 methyl cellulose Polymers 0.000 claims description 5
- 239000001923 methylcellulose Substances 0.000 claims description 5
- 235000010981 methylcellulose Nutrition 0.000 claims description 5
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 150000003505 terpenes Chemical class 0.000 claims description 4
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical group CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 3
- 229930182837 (R)-adrenaline Natural products 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 244000215068 Acacia senegal Species 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 239000004373 Pullulan Substances 0.000 claims description 3
- 229920001218 Pullulan Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 229920001615 Tragacanth Polymers 0.000 claims description 3
- 229960004538 alprazolam Drugs 0.000 claims description 3
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000305 astragalus gummifer gum Substances 0.000 claims description 3
- 230000001851 biosynthetic effect Effects 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 239000000412 dendrimer Substances 0.000 claims description 3
- 229920000736 dendritic polymer Polymers 0.000 claims description 3
- 229960003529 diazepam Drugs 0.000 claims description 3
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 claims description 3
- 229960005139 epinephrine Drugs 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 229920000587 hyperbranched polymer Polymers 0.000 claims description 3
- 229920001308 poly(aminoacid) Polymers 0.000 claims description 3
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 3
- 239000004584 polyacrylic acid Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 3
- 235000019423 pullulan Nutrition 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 229920003169 water-soluble polymer Polymers 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims description 2
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 2
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 claims description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 claims description 2
- 229930002886 farnesol Natural products 0.000 claims description 2
- 229940043259 farnesol Drugs 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- 235000020778 linoleic acid Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229930004725 sesquiterpene Natural products 0.000 claims description 2
- 150000004354 sesquiterpene derivatives Chemical class 0.000 claims description 2
- 235000007586 terpenes Nutrition 0.000 claims description 2
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims description 2
- 125000001474 phenylpropanoid group Chemical group 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 claims 1
- 125000002871 cinnamic aldehydes group Chemical group 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000006071 cream Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023104610A JP2023134518A (ja) | 2016-05-05 | 2023-06-27 | 透過性増強された医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662331993P | 2016-05-05 | 2016-05-05 | |
| US62/331,993 | 2016-05-05 | ||
| PCT/US2017/031170 WO2017192923A1 (en) | 2016-05-05 | 2017-05-04 | Pharmaceutical compositions with enhanced permeation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023104610A Division JP2023134518A (ja) | 2016-05-05 | 2023-06-27 | 透過性増強された医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019519488A JP2019519488A (ja) | 2019-07-11 |
| JP2019519488A5 true JP2019519488A5 (enExample) | 2020-06-25 |
Family
ID=58708068
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558225A Pending JP2019519488A (ja) | 2016-05-05 | 2017-05-04 | 透過性増強された医薬組成物 |
| JP2023104610A Pending JP2023134518A (ja) | 2016-05-05 | 2023-06-27 | 透過性増強された医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023104610A Pending JP2023134518A (ja) | 2016-05-05 | 2023-06-27 | 透過性増強された医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20170290776A1 (enExample) |
| EP (1) | EP3452024A1 (enExample) |
| JP (2) | JP2019519488A (enExample) |
| KR (1) | KR102536696B1 (enExample) |
| CN (1) | CN109310647A (enExample) |
| BR (1) | BR112018072467A2 (enExample) |
| CA (1) | CA3022797A1 (enExample) |
| IL (2) | IL262751B2 (enExample) |
| WO (1) | WO2017192923A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| KR20230137362A (ko) | 2016-05-05 | 2023-10-04 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 조성물 |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| JP2020500220A (ja) | 2016-11-15 | 2020-01-09 | クラリア ファーマ ホールディング エービー | 医薬製剤 |
| WO2018129499A1 (en) * | 2017-01-09 | 2018-07-12 | Verily Life Sciences Llc | Systems and methods for wearable emergency drug injection devices |
| GB201709141D0 (en) | 2017-06-08 | 2017-07-26 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| EP3687510A1 (en) * | 2017-09-27 | 2020-08-05 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| CA3076815A1 (en) * | 2017-09-27 | 2019-04-04 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| CN107903322B (zh) * | 2017-10-10 | 2022-03-08 | 宜宾学院 | 一种基于黄樟素环氧化改性制备抗菌胶原的方法 |
| GB201808462D0 (en) | 2018-05-23 | 2018-07-11 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| US11648197B2 (en) | 2018-06-28 | 2023-05-16 | Arx, Llc | Dispensing method for producing dissolvable unit dose film constructs |
| CN112955124A (zh) * | 2018-09-07 | 2021-06-11 | 阿奎蒂夫疗法公司 | 具有精确的活性物溶出谱的口腔膜组合物和剂型 |
| AU2020373100A1 (en) * | 2019-11-01 | 2022-05-19 | Aquestive Therapeutics, Inc. | Prodrug compositions and methods of treatment |
| EP4058029B1 (en) * | 2019-11-14 | 2025-03-26 | Aquestive Therapeutics, Inc. | Multimodal compositions and methods of treatment |
| CA3160750A1 (en) | 2019-12-09 | 2021-06-17 | Anthony Richard Gerardi | Oral product comprising a cannabinoid |
| DE102020122557A1 (de) * | 2020-08-28 | 2022-03-03 | Lts Lohmann Therapie-Systeme Ag | Mucosa-Perforierung |
| WO2022074127A2 (en) * | 2020-10-08 | 2022-04-14 | Catalent U.K. Swindon Zydis Limited | Stable oral dispersible formulation for epinephrine and salts or solvates thereof |
| US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
| JP2025029732A (ja) | 2023-08-22 | 2025-03-07 | 三菱電機株式会社 | ゲート駆動装置 |
| CN120037250A (zh) * | 2025-04-07 | 2025-05-27 | 江苏知原药业股份有限公司 | 一种伊维菌素外用药物组合物、制备方法及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1357891A (en) | 1920-07-15 | 1920-11-02 | Henry S Murray | Portable instantaneous water-heater |
| US20040265353A1 (en) * | 1995-07-28 | 2004-12-30 | Zars, Inc. | Systems and methods for treating panic attacks |
| US7666337B2 (en) | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| RU2328275C2 (ru) * | 2002-10-25 | 2008-07-10 | Лабофарм Инк. | Композиции трамадола пролонгированного высвобождения с 24-часовым действием |
| US20040096569A1 (en) * | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
| US20050266085A1 (en) * | 2004-05-28 | 2005-12-01 | Warner Kevin S | Gelled emulsion and microemulsion formulations for dermal drug delivery |
| US20070202163A1 (en) * | 2005-09-09 | 2007-08-30 | Mutasem Rawas-Qalaji | Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| IL175338A0 (en) * | 2006-05-01 | 2006-09-05 | Biota Ltd | Orally administrable films and preparation thereof |
| KR101226165B1 (ko) * | 2009-07-23 | 2013-01-24 | 가부시키가이샤 이기스 | 피부 외용제 조성물 |
| CA2801620A1 (en) * | 2010-07-06 | 2012-01-12 | Gruenenthal Gmbh | Novel gastro-retentive dosage forms comprising a gaba analog and an opioid |
| WO2013063614A1 (en) * | 2011-10-28 | 2013-05-02 | Sung-Yun Kwon | Dissolving solid solution perforator patch for migraine treatment |
| KR20230137362A (ko) * | 2016-05-05 | 2023-10-04 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 조성물 |
-
2017
- 2017-05-04 WO PCT/US2017/031170 patent/WO2017192923A1/en not_active Ceased
- 2017-05-04 JP JP2018558225A patent/JP2019519488A/ja active Pending
- 2017-05-04 IL IL262751A patent/IL262751B2/en unknown
- 2017-05-04 EP EP17723617.1A patent/EP3452024A1/en active Pending
- 2017-05-04 IL IL318880A patent/IL318880A/en unknown
- 2017-05-04 US US15/587,376 patent/US20170290776A1/en not_active Abandoned
- 2017-05-04 BR BR112018072467-0A patent/BR112018072467A2/pt not_active Application Discontinuation
- 2017-05-04 KR KR1020187035236A patent/KR102536696B1/ko active Active
- 2017-05-04 CN CN201780037588.XA patent/CN109310647A/zh active Pending
- 2017-05-04 CA CA3022797A patent/CA3022797A1/en active Pending
-
2023
- 2023-06-27 JP JP2023104610A patent/JP2023134518A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019519488A5 (enExample) | ||
| JP2019519487A5 (enExample) | ||
| JP2020535162A5 (enExample) | ||
| KR102186313B1 (ko) | 붕괴 가능한 캡슐 및 그 제조 방법 및 붕괴 가능한 캡슐을 포함하는 흡연 기구 | |
| Putro et al. | Polysaccharides gums in drug delivery systems: A review | |
| JP6852058B2 (ja) | 分散された風味剤を持つエアロゾル発生物品 | |
| Shirwaikar et al. | Herbal excipients in novel drug delivery systems | |
| HRP20170864T1 (hr) | Čvrsti dozni oblici s kontroliranim oslobađanjem | |
| JP6598841B2 (ja) | ツーピース硬カプセル用の耐酸性バンド溶液 | |
| IL273485B1 (en) | Enhanced delivery epinephrine and prodrug compositions | |
| WO2014154029A1 (zh) | 复合骨架材料及其药物组合物 | |
| TW201944985A (zh) | 軟膠囊皮膜組合物 | |
| JP6312689B2 (ja) | 植物性シームレスカプセル、及びその利用 | |
| AU2014380905A1 (en) | Composition of oily, pungent and odoriferous substances and a process of preparation thereof | |
| JP6441811B2 (ja) | 複合体形成用組成物、そこから形成された複合体、及びそれを含む経口摂取用組成物 | |
| EP3386320A1 (en) | Vitamin formulation | |
| Jain et al. | Natural excipients-an alternative to synthetic excipients: a comprehensive review | |
| Sharma et al. | Use of natural superdisintegrant in mouth dissolving tablet-an emerging trend | |
| JP2013249283A5 (enExample) | ||
| Ofori-Kwakye et al. | Mechanical and tablet coating properties of cashew tree (anacardium occidentale l) gum-based films | |
| Kulkarni et al. | Effect of tamarind seed polysaccharide on dissolution behaviour of ibuprofen tablets | |
| Aneebuddin et al. | Recent Trends in the Chemistry of Polymers used in Oral Drug Delivery Systems | |
| Shinkar et al. | Superdisintegrants: A Review | |
| JP6570524B2 (ja) | コーティング組成物 | |
| CN103933574B (zh) | 用于制备空心胶囊的植物质胶及其应用 |